Form D — TriSalus Life Sciences, Inc.
0001231919-25-000045 · filed 2025-05-08
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $22,000,000
- Total sold
- $22,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- TriSalus Life Sciences, Inc.
- CIK
- 1826667
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 6272 WEST 91ST AVENUE
WESTMINSTER, CO 80031 - Phone
- 415 336 8917
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sean Murphy · DirectorWestminster, CO Find on LinkedIn ↗
-
Mary Szela · Executive OfficerWestminster, CO Find on LinkedIn ↗
-
James Young · Executive OfficerWestminster, CO Find on LinkedIn ↗
-
William F. Valle · DirectorWestminster, CO Find on LinkedIn ↗
-
Arjun Desai · DirectorWestminster, CO Find on LinkedIn ↗
-
Andrew von Eschenbach · DirectorWestminster, CO Find on LinkedIn ↗
-
Kerry Hicks · DirectorWestminster, CO Find on LinkedIn ↗
-
Gary Gordon · DirectorWestminster, CO Find on LinkedIn ↗
-
Brian Cox · Executive OfficerWestminster, CO Find on LinkedIn ↗
-
David J. Matlin · DirectorWestminster, CO Find on LinkedIn ↗
-
Mats Wahlstrom · DirectorWestminster, CO Find on LinkedIn ↗
-
Richard Marshak · Executive OfficerWestminster, CO Find on LinkedIn ↗
-
Jennifer Stevens · Executive OfficerWestminster, CO Find on LinkedIn ↗
-
Jodi Devlin · Executive OfficerWestminster, CO Find on LinkedIn ↗
View original on SEC EDGAR.